Code | CSB-RA004555A0HU |
Size | US$210 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
Application | Recommended Dilution |
---|---|
WB | 1:500-1:5000 |
IF | 1:20-1:200 |
The development of the CASP9 recombinant monoclonal antibody involves the utilization of DNA recombinant technology and in vitro genetic manipulation. Initially, animals are immunized with a synthesized peptide derived from human CASP9, which triggers an immune response and allows for the isolation of B cells. After thorough screening and selection, B cells displaying the desired specificity are identified. The genes encoding the light and heavy chains of the CASP9 antibody are then amplified through PCR and inserted into a plasmid vector. This recombinant vector is subsequently introduced into host cells for antibody expression. The CASP9 recombinant monoclonal antibody is purified from the cell culture supernatant using affinity chromatography. This purified antibody exhibits strong affinity and selectivity for human CASP9 protein, enabling its application in ELISA, WB, IF, and FC.
The CASP9 protein plays a crucial role in apoptosis. It is a protease enzyme that is activated in response to signals that initiate the apoptotic process. Once activated, CASP9 cleaves and activates downstream caspases, ultimately leading to the dismantling of the cell. In addition to its role in apoptosis, CASP9 has also been implicated in other cellular processes, such as inflammation and immune response. Dysfunction of CASP9 has been associated with various diseases, including cancer and neurodegenerative disorders.
There are currently no reviews for this product.